Results 51 to 60 of about 311,841 (295)

BAHUSANSKRUTIK VAD

open access: yes, 2022
Sansruti ya sankalpanechya anek vyakhya aahet. Sankruti hi pravahi sankalpana aahe. yamadhe aata konatya shanka nahi. sanskruti shabdacha artha satatyane badalat asato.
openaire   +1 more source

Ferroptosis Suppression by the M6A Reader IGF2BP1 Underlies Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

open access: yesAdvanced Science, EarlyView.
IGF2BP1 promotes gemcitabine resistance in pancreatic cancer by stabilizing m6A‐modified FTH1 transcripts and protecting them in stress granules, thereby suppressing ferroptosis. Pharmacological inhibition of IGF2BP1 disrupts this protective pathway, restores ferroptotic sensitivity, and enhances gemcitabine efficacy in resistant tumors.
Ying‐Qin Zhu   +10 more
wiley   +1 more source

Preparación y Educación en el manejo de la Vía Aérea. Revisión 2015

open access: yesRevista Electrónica de AnestesiaR, 1970
El propósito de la Educación Médica en cualquier campo, prepara al profesional para la adquisición de conocimientos, habilidades y profesionalidad necesaria para aportar un cuidado correcto al paciente.
Marisa Mariscal Flores   +1 more
doaj   +1 more source

Berlin Heart EXCOR en el periodo neonatal

open access: yesCirugía Cardiovascular, 2021
Resumen: El trasplante cardiaco es una terapia bien establecida para el tratamiento de la insuficiencia cardiaca terminal en pacientes pediátricos. Sin embargo, los niños pequeños presentan un mayor riesgo de muerte en lista de espera.
Carlos M. Merino   +5 more
doaj   +1 more source

Carrier‐Free Berberine/Nitidine Chloride Self‐Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma

open access: yesAdvanced Science, EarlyView.
A schematic illustrating the fabrication process and ferroptosis‐mediated therapeutic mechanism of carrier‐free self‐assembled BBR/NC‐SAPs for overcoming bortezomib resistance in multiple myeloma. ABSTRACT Therapeutic relapse driven by bortezomib resistance represents a formidable clinical barrier in the management of multiple myeloma (MM).
Yiwen Lv   +16 more
wiley   +1 more source

Durable mechanical circulatory support in paediatric heart failure: The experience at Great Ormond Street Hospital

open access: yesCirugía Cardiovascular, 2019
Durable ventricular assist devices (VAD), despite being a standard therapy for adults in end-stage heart failure, are not so extended among the paediatric population for some reasons.
Ana Redondo   +4 more
doaj   +1 more source

Targeting the PHB2–ACSL3 Lipid‐Remodeling Axis Overcomes Cisplatin Resistance by Restoring Ferroptosis in Gastric Cancer

open access: yesAdvanced Science, EarlyView.
ABSTRACT Platinum‐based chemotherapy resistance remains a major obstacle in gastric cancer (GC) treatment. Through integrated transcriptomic profiling of cisplatin‐resistant xenografts and pharmacogenomic interrogation of the NCI‐60 dataset, we identified Prohibitin‐2 (PHB2) as a previously unrecognized determinant of chemoresistance.
Liang Xu   +10 more
wiley   +1 more source

3D FACIAL MORPHOMETRY IN PATIENS WITH OCULO-AURICULO-VERTEBRAL SPECTRUM

open access: yesČeská Stomatologie a Praktické Zubní Lékařství, 2019
Introduction and aim: Oculo-auriculo-vertebral spectrum (OAVS) is a congenital complex of extremely variable phenotypes. Typically, unilaterally affected structuresare facial structures developing from the first and second branchial arches and first ...
P. Švihlíková Poláčková   +2 more
doaj   +1 more source

KLF5 Downregulation Links Impaired BNIP3‐Mediated Mitophagy to Inflammatory Valve Remodeling in Calcific Aortic Valve Disease

open access: yesAdvanced Science, EarlyView.
In human CAVD, KLF5 is reduced in VIC‐rich regions and remodeling/stress‐associated VIC states. In VICs, KLF5 sustains BNIP3 promoter activity and BNIP3‐mediated mitophagy, thereby limiting cytosolic mtDNA accumulation. KLF5 loss weakens mitochondrial quality control and enhances mtDNA‐sensitive STING/NF‐κB/NLRP3 inflammatory signaling under osteogenic
Jin‐Hui Bian   +13 more
wiley   +1 more source

DIXDC1 Promotes Lymphatic Metastasis and Resistance to Cuproptosis in Bladder Cancer Through Mediating DLAT

open access: yesAdvanced Science, EarlyView.
DIXDC1 drives bladder cancer progression by binding and stabilizing DLAT. This axis enhances NEK7 and CCNE2 mRNA stability to promote proliferation and lymphatic metastasis, while limiting copper‐induced DLAT oligomerization to reduce cuproptosis sensitivity, identifying DIXDC1 as a potential target linking metastasis with cuproptosis resistance ...
Hongqiong Li   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy